Abe Alexander is a principal at Grant & Eisenhofer, where he focuses on securities fraud litigation.
Prior to joining G&E, as a principal member of the trial team prosecuting In re Merck Vioxx Securities Litigation, Mr. Alexander helped recover over $1.06 billion on behalf of injured investors. The case, which asserted claims arising out of the Defendants’ alleged misrepresentations concerning the safety profile of Merck's pain-killer, VIOXX, was settled shortly before trial and after more than 10 years of litigation, during which time plaintiffs achieved a unanimous and groundbreaking victory for investors at the U.S. Supreme Court. The settlement is the largest securities recovery ever achieved against a pharmaceutical company.
Mr. Alexander was a principal member of the trial team that prosecuted In re Schering-Plough Corp./ENHANCE Securities Litigation and In re Merck & Co., Inc. Vytorin/Zetia Securities Litigation, which settled on the eve of trial for a combined $688 million. This $688 million settlement represents the second largest securities class action recovery against a pharmaceutical company in history.
He has obtained several additional significant recoveries on behalf of investors in pharmaceutical and life sciences companies, including:
- a $142 million recovery in Medina v. Clovis Oncology, Inc., a securities fraud class action arising from Defendants’ alleged misstatements about the efficacy and safety of its most important drug;
- a $77.5 million recovery in In re Myriad Genetics, Inc. Securities Litigation, a case arising from alleged misstatements concerning genetic testing products;
- a $55 million recovery in In re HeartWare International, Inc. Securities Litigation, a case arising from Defendants’ alleged misstatements about the device-maker’s compliance with FDA regulations and the performance of its key heart pump;
- a $44 million recovery in In re Adeptus Health Inc. Securities Litigation, a case arising from alleged misstatements concerning the liquidity and cash flow of the country's largest operator of freestanding emergency rooms; and
- a $39 million recovery in In re BioMarin Pharmaceutical Inc. Securities Litigation, a case arising from alleged misstatements concerning FDA review of a biologic.
Mr. Alexander secured a $450 million recovery in In re Kraft Heinz Securities Litigation, a case arising from alleged misstatements concerning the sustainability of Kraft Heinz’s cost-cutting measures and its brand investment and operations. Mr. Alexander secured a $149 million recovery on behalf of investors in Equifax, Inc., helping to lead a securities class action arising from one of the largest data breaches in American history. He also played a lead role in securing a $150 million settlement of investors’ claims against JPMorgan Chase arising from alleged misrepresentations concerning the trading activities of the so-called “London Whale.” Mr. Alexander additionally secured a $95 million recovery on behalf of investors in Cognizant Technology Solutions dealing with alleged false statements and illegal payments to Indian governmental officials to secure favorable permits.
Mr. Alexander was named to the 2022 list of “Rising Stars of the Plaintiff's Bar” by the National Law Journal, recognized in the 2021 list of "Risings Stars" by Law360, and chosen by Benchmark Litigation for its “40 & Under Hot List.” Super Lawyers has also regularly selected Mr. Alexander to its list of New York “Rising Stars” in recognition of his accomplishments.
Prior to joining G&E, Mr. Alexander was a partner at a New York firm representing institutional investors in securities and corporate governance litigation.
Mr. Alexander served as a judicial clerk to Chief Justice Michael L. Bender of the Colorado Supreme Court. He earned his J.D. from University of Colorado Law School, and his B.A. from New York University in Analytic Philosophy.